PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 7,400,460 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementUnderwriting Agreement • November 13th, 2020 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • New York
Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 6,096,112 shares of its common stock, par value $0.001 per share (the “Shares”), and the stockholder of the Company named in Schedule B (the “Selling Stockholder”) proposes, subject to the terms and conditions of this underwriting agreement (this “Agreement”), to sell to the Underwriters 1,304,348 Shares. The 6,096,112 Shares to be sold by the Company and the 1,304,348 Shares to be sold by the Selling Stockholder are collectively called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 914,416 Shares, and the Selling Stockholder has granted to the Underwriters an option to purchase up to an additional 195,652 Shares. Such additional 914,416 Shares to be sold by the Company and 195,652 Shares to be sold by the Selling Stockholder,
